The FDA's kinder, gentler attitude toward India hasn't stopped tough enforcement moves

The FDA may have been all smiles and pleasantries at a recent meeting with its counterparts in India, but that hasn't stopped it from taking serious action against the country's manufacturing plants. The latest: a ban on imports from two more Ipca Laboratories facilities. More from FiercePharmaAsia